5 Results Sort by:
A 3D In Vitro Model of the Human Locus Coeruleus
Application A brain organoid model for the human locus coeruleus to study its function and dysfunction in neurological diseases. Key Benefits Locus coeruleus region-specific neural organoid model for studying this deep region of the human brain. The organoid synthesizes norepinephrine, allowing for study of diseases related to these neurotransmitters. The...
Published: 4/8/2024       Contributor(s): Fikri Birey, David Weinshenker
Tyrosinase Viral Vectors for the Generation of Rodents Exhibiting Time -Dependent Production and Intracellular Accumulation of Human-Like Neuromelanin
­ Application Improved study of neurodegenerative diseases on mice. Key Benefits Ability to study neuromelanin’s association with neurodegenerative diseases with mice. Researchers can analyze overexpression of tyrosinase on specific cell types. Market Summary Neurodegenerative diseases such as Alzheimer’s and Parkinson’s...
Published: 7/28/2023       Contributor(s): David Weinshenker, Alexa Iannitelli
3q29 Deletion Mice
Application Mouse models with the deletion of 3q29 for the study of neurological disorders such as schizophrenia, autism, and anxiety disorders. Technical Summary Copy Number Variants (CNV’s) are large genomic deletion or duplications. One of the CNV’s, the 3q29 deletion, confers more than 40 fold increase in risk of schizophrenia. Most...
Published: 7/28/2023       Contributor(s): Tamara Caspary, David Weinshenker, Stephen Theodore Warren
Transgenic Human Dopamine Beta-hydroxylase Mouse Model
Applications Mouse model that utilizes a BAC to express human dopamine beta-hydroxylase in the brain. Key Benefits In vivo approach to dissect role of single genes in the nervous system. May be used in the study of how human variants of dopamine beta-hydroxylase affect norepinephrine signaling in the brain. Technical Summary Dopamine beta-hydroxylase...
Published: 11/27/2023       Contributor(s): Joseph Cubells, David Weinshenker
Hyperactive Rats
Application Antidepressant drug screening for depression studies. Technical Summary We have developed different lines of rats by behavioral testing and then selective breeding of those showing desired characteristics in attempting to rat models for study of affective disorders. The lines were directed at possibly improving both drug screens (i.e.,...
Published: 7/28/2023       Contributor(s): Jay Weiss, Katherine Boss-Williams, David Weinshenker